Stay updated on PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib
Sign up to get notified when there's something new on the PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib page.

Latest updates to the PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib page
- Check4 days agoChange DetectedThe page now presents the PAOLA-1 clinical trial record, including its study design, eligibility criteria, locations, outcomes, and related publications.SummaryDifference100%

- Check11 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the study record continues to display a 403 Forbidden page.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA banner about NIH’s terminology transition appears above the 403 error page, and the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the detailed PAOLA-1 study listing and related content such as eligibility, locations, and study documents.SummaryDifference16%

- Check60 days agoChange DetectedA new page revision tag 'Revision: v3.7.0' was added. Several related topics entries, including 'Ovarian cancer', 'related topics:', 'MedlinePlus Genetics', and the older 'Revision: v3.6.6', were removed.SummaryDifference0.1%

Stay in the know with updates to PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib
Enter your email address, and we'll notify you when there's something new on the PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib page.